Related Experiment Video
Updated: Oct 20, 2025

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Prevalence of Hypomagnesemia among Elderly Patients attending a Tertiary Care Center: A Descriptive Cross-sectional
Surakchhya Gautam1, Anju Khapunj2
1Department of Biochemistry, Kathmandu Medical College, Duwakot, Bhaktapur, Nepal.
Introduction:
Magnesium deficiency is common in the elderly and critically ill population and has been associated with a prolonged ICU stay. The knowledge of hypomagnesemia is essential as it could have prognostic and therapeutic implications in the elderly population. This study aimed to estimate the prevalence of hypomagnesemic in the elderly population visiting a tertiary care center.
Methods:
This descriptive cross-sectional study was conducted in a tertiary care hospital from March 21, 2020 to September 21, 2020. After obtaining ethical clearance from the institutional review committee (Ref. 2003202008), convenience sampling was done. Data were collected and entered in Microsoft Excel version 2007. Point estimate at 95% Confidence Interval was calculated along with frequency and proportion for binary data.
Results:
Out of 384 participants, 174 (45%) participants were found to have deranged magnesium levels, in which 111 (29%) (31.3-26.7 at 95% Confidence Interval) were found to be hypomagnesemia. Among them, 62 (29.4%) males and 49 (28.5%) females were hypomagnesemia. The average level of serum magnesium was 2.02±0.76 mg/dl ranging from 0.03 to 4.71. The mean age of participants was 70.31±8.13 years, among which the participants between the age group of 71-80 years presented with a maximum percentage of hypomagnesemia.
Conclusions:
The present study has shown that an apparently-healthy elderly population may have a magnesium deficiency that may need to be identified and treated for optimizing clinical care. Further multicentric studies with a greater sample size should be done in this field, which will benefit the elderly population.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
